Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAR 02 (StarPan Study)
2007-001533-34Phase 2Completed
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- May 2007
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of panitumumab, fluorouracil and oxaliplatin in rectal adenocarcinoma and rectal cancer, sponsored by Sant'Orsola-Malpighi University Hospital. Primary endpoint: Pathological complete response rate. Started May 2007; status: completed.
02
Drugs
panitumumabfluorouraciloxaliplatin
03
Conditions
rectal adenocarcinomarectal cancer
Beyond the preview
Go deeper on 2007-001533-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001533-34.